Drug Profile
BSL 4
Latest Information Update: 16 Nov 1998
Price :
$50
*
At a glance
- Originator Dainippon Ink & Chemicals
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 16 Nov 1998 Discontinued-Preclinical for HIV infections treatment in Japan (PO)
- 31 Jul 1998 No-Development-Reported for HIV infections treatment in Japan (PO)
- 26 Nov 1996 New profile